Use of the analytic hierarchy process for medication decision-making in type 2 diabetes.

ABSTRACT:

Aim

To investigate the feasibility and utility of the Analytic Hierarchy Process (AHP) for medication decision-making in type 2 diabetes.

Methods

We conducted an AHP with nine diabetes experts using structured interviews to rank add-on therapies (to metformin) for type 2 diabetes. During the AHP, participants compared treatment alternatives relative to eight outcomes (hemoglobin A1c-lowering and seven potential harms) and the relative importance of the different outcomes. The AHP model and instrument were pre-tested and pilot-tested prior to use. Results were discussed and an evaluation of the AHP was conducted during a group session. We conducted the quantitative analysis using Expert Choice software with the ideal mode to determine the priority of treatment alternatives.

SUBMITTER: Maruthur NM 

PROVIDER: S-EPMC4441461 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature